Cargando…

Evaluation of 511 keV photon attenuation by a novel 32-channel phased array prospectively designed for cardiovascular hybrid PET/MRI imaging

BACKGROUND: Simultaneous cardiovascular imaging with positron emission tomography (PET) and magnetic resonance imaging (MRI) requires tools such as radio frequency (RF) phased arrays to achieve high temporal and spatial resolution in the MRI, as well as accurate quantification of PET. Today, high-de...

Descripción completa

Detalles Bibliográficos
Autores principales: Farag, Adam, Thompson, R. Terry, Thiessen, Jonathan D., Biernaski, Heather, Prato, Frank S., Théberge, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324084/
https://www.ncbi.nlm.nih.gov/pubmed/32626841
http://dx.doi.org/10.1186/s41824-020-00076-w
_version_ 1783551876943314944
author Farag, Adam
Thompson, R. Terry
Thiessen, Jonathan D.
Biernaski, Heather
Prato, Frank S.
Théberge, Jean
author_facet Farag, Adam
Thompson, R. Terry
Thiessen, Jonathan D.
Biernaski, Heather
Prato, Frank S.
Théberge, Jean
author_sort Farag, Adam
collection PubMed
description BACKGROUND: Simultaneous cardiovascular imaging with positron emission tomography (PET) and magnetic resonance imaging (MRI) requires tools such as radio frequency (RF) phased arrays to achieve high temporal and spatial resolution in the MRI, as well as accurate quantification of PET. Today, high-density phased arrays (> 16 channels) used for cardiovascular PET/MRI are not designed to achieve low PET attenuation, and correcting the PET attenuation they cause requires off-line reconstruction, extra time and resources. PURPOSE: Motivated by previous work assessing the MRI performance of a novel prospectively designed 32-channel phased array, this study assessed the PET image quality with this array in place. Guided by NEMA standards, PET performance was measured using global PET counts, regional background variation (BV), contrast recovery (CR) and contrast-to-noise ratio (CNR) for both the novel array and standard arrays (mMR 12-channel and MRI 32-channel). Nonattenuation-corrected (NAC) data from all arrays (and each part of the array) were processed and compared to no-array, and relative percentage difference (RPD) of the global means was estimated and reported for each part of the arrays. Attenuation correction (AC) of PET images (water in the phantom) using two approaches, MR-based AC map (MRAC) and dual-energy CT-based map (DCTAC), was performed, and RPD compared for each part of the arrays. Percent mean attenuation within regions of interests of the phantom images from each array were compared using a two-way analysis of variance (ANOVA). RESULTS: The NAC data of the anterior part of the novel array recorded the least PET attenuation (≤ 2%); while the full novel array (anterior and posterior together) AC data, produced by MRAC and DCTAC approaches, recorded attenuation of 1.5 ± 2.9% and 0.0 ± 2.5%, respectively. The novel array PET count loss was significantly lower (p = 0.001) than those caused by the standard arrays. CONCLUSIONS: Results of this novel 32-channel cardiac array PET performance evaluation, together with its previously reported MRI performance assessment, suggest the novel array to be a strong alternative to the standard arrays currently used for cardiovascular hybrid PET/MRI imaging. It enables accurate PET quantification and high-temporal and spatial resolution for MR imaging.
format Online
Article
Text
id pubmed-7324084
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73240842020-07-02 Evaluation of 511 keV photon attenuation by a novel 32-channel phased array prospectively designed for cardiovascular hybrid PET/MRI imaging Farag, Adam Thompson, R. Terry Thiessen, Jonathan D. Biernaski, Heather Prato, Frank S. Théberge, Jean Eur J Hybrid Imaging Original Article BACKGROUND: Simultaneous cardiovascular imaging with positron emission tomography (PET) and magnetic resonance imaging (MRI) requires tools such as radio frequency (RF) phased arrays to achieve high temporal and spatial resolution in the MRI, as well as accurate quantification of PET. Today, high-density phased arrays (> 16 channels) used for cardiovascular PET/MRI are not designed to achieve low PET attenuation, and correcting the PET attenuation they cause requires off-line reconstruction, extra time and resources. PURPOSE: Motivated by previous work assessing the MRI performance of a novel prospectively designed 32-channel phased array, this study assessed the PET image quality with this array in place. Guided by NEMA standards, PET performance was measured using global PET counts, regional background variation (BV), contrast recovery (CR) and contrast-to-noise ratio (CNR) for both the novel array and standard arrays (mMR 12-channel and MRI 32-channel). Nonattenuation-corrected (NAC) data from all arrays (and each part of the array) were processed and compared to no-array, and relative percentage difference (RPD) of the global means was estimated and reported for each part of the arrays. Attenuation correction (AC) of PET images (water in the phantom) using two approaches, MR-based AC map (MRAC) and dual-energy CT-based map (DCTAC), was performed, and RPD compared for each part of the arrays. Percent mean attenuation within regions of interests of the phantom images from each array were compared using a two-way analysis of variance (ANOVA). RESULTS: The NAC data of the anterior part of the novel array recorded the least PET attenuation (≤ 2%); while the full novel array (anterior and posterior together) AC data, produced by MRAC and DCTAC approaches, recorded attenuation of 1.5 ± 2.9% and 0.0 ± 2.5%, respectively. The novel array PET count loss was significantly lower (p = 0.001) than those caused by the standard arrays. CONCLUSIONS: Results of this novel 32-channel cardiac array PET performance evaluation, together with its previously reported MRI performance assessment, suggest the novel array to be a strong alternative to the standard arrays currently used for cardiovascular hybrid PET/MRI imaging. It enables accurate PET quantification and high-temporal and spatial resolution for MR imaging. Springer International Publishing 2020-05-12 /pmc/articles/PMC7324084/ /pubmed/32626841 http://dx.doi.org/10.1186/s41824-020-00076-w Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Farag, Adam
Thompson, R. Terry
Thiessen, Jonathan D.
Biernaski, Heather
Prato, Frank S.
Théberge, Jean
Evaluation of 511 keV photon attenuation by a novel 32-channel phased array prospectively designed for cardiovascular hybrid PET/MRI imaging
title Evaluation of 511 keV photon attenuation by a novel 32-channel phased array prospectively designed for cardiovascular hybrid PET/MRI imaging
title_full Evaluation of 511 keV photon attenuation by a novel 32-channel phased array prospectively designed for cardiovascular hybrid PET/MRI imaging
title_fullStr Evaluation of 511 keV photon attenuation by a novel 32-channel phased array prospectively designed for cardiovascular hybrid PET/MRI imaging
title_full_unstemmed Evaluation of 511 keV photon attenuation by a novel 32-channel phased array prospectively designed for cardiovascular hybrid PET/MRI imaging
title_short Evaluation of 511 keV photon attenuation by a novel 32-channel phased array prospectively designed for cardiovascular hybrid PET/MRI imaging
title_sort evaluation of 511 kev photon attenuation by a novel 32-channel phased array prospectively designed for cardiovascular hybrid pet/mri imaging
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324084/
https://www.ncbi.nlm.nih.gov/pubmed/32626841
http://dx.doi.org/10.1186/s41824-020-00076-w
work_keys_str_mv AT faragadam evaluationof511kevphotonattenuationbyanovel32channelphasedarrayprospectivelydesignedforcardiovascularhybridpetmriimaging
AT thompsonrterry evaluationof511kevphotonattenuationbyanovel32channelphasedarrayprospectivelydesignedforcardiovascularhybridpetmriimaging
AT thiessenjonathand evaluationof511kevphotonattenuationbyanovel32channelphasedarrayprospectivelydesignedforcardiovascularhybridpetmriimaging
AT biernaskiheather evaluationof511kevphotonattenuationbyanovel32channelphasedarrayprospectivelydesignedforcardiovascularhybridpetmriimaging
AT pratofranks evaluationof511kevphotonattenuationbyanovel32channelphasedarrayprospectivelydesignedforcardiovascularhybridpetmriimaging
AT thebergejean evaluationof511kevphotonattenuationbyanovel32channelphasedarrayprospectivelydesignedforcardiovascularhybridpetmriimaging